Immunomedics (IMMU) Receives U.S. Patents for Antibody-SN-38 Conjugates, F-18 Labeling of Peptides and Proteins
Tweet Send to a Friend
Immunomedics, Inc. (Nasdaq: IMMU) announced the issuance of U.S. patent no. 8,617,558 for additional claims under the patent family "Camptothecin-binding ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
